Study Assessing PTI-428 Safety, Tolerability, and Pharmacokinetics in Subjects With Cystic Fibrosis
Clinical trial NCT02718495 · COMPLETED
Trial details
- NCT number
- NCT02718495
- Sponsor
- Proteostasis Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-19
- Primary completion
- 2017-11-28
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.